EspaƱol
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 29 for your search:
Drug:  acetylsalicylic acid
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Supportive care
Status: Enrolling by invitation
Age: 18 to 80
Sponsor: Other
Protocol IDs: PZ-1001-403-NS, NCT01621451

2.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Status: Enrolling by invitation
Age: 65 and over
Sponsor: NCI, Other
Protocol IDs: 3U01AG029824-02S1, NCT01968798

3.

Phase: Phase IV
Type: Health services research, Supportive care
Status: Enrolling by invitation
Age: 18 and over
Sponsor: Other
Protocol IDs: RMC-13-0666, NCT02350543

4.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 30 and over
Sponsor:
Protocol IDs: PVSG-10

5.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-875001, MAYO-875001, NCCTG-87-50-01

6.

Phase: Phase III
Type: Prevention
Status: Completed
Age: over 30 to under 75
Sponsor: NCI, Other
Protocol IDs: CDR0000078380, CLB-9270, E-C9270, NCCTG-949251, NCI-P93-0048, NCT00002527

7.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: BARTS-DAVDAS, EU-20610, ISRCTN13255144, NCT00316927

8.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Health services research, Prevention
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000491649, OCTO-003, 2004-003836-77, ISRCTN85156844, OCTO-ASPECT, RADCLIFFE-32, ZENECA-RADCLIFFE-32, EUDRACT-2004-003836-77, EU-20628, NCT00357682

9.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03150, CDR0000404161, E4A03, U10CA021115, U10CA180820, ECOG-E4A03, NCT00098475

10.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 45 and over
Sponsor: NCI, Other
Protocol IDs: 69, R01HL043851, HL043851, CA047988, NCT00000479

11.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: BRMP-8802D, NCI-88-C-84D, NCI-T88-0103N, T88-0103

12.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: HEMMYL0018, AR_MM_PI_007, SU-05062011-7711, 19092, NCT01355705

13.

Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000068028, NCI-00-C-0128, MB-401, NCI-T99-0066, T99-0066, NCT00020189

14.

Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: MAYO-851901, NCI-T85-0264D, T85-0264

15.

Phase: Phase II
Type: Supportive care
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: RPMI-DS-8816, NCI-V88-0553

16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 05-0427 / 201107340, NCT00263211

17.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00838, MAY04-4-01, CDR0000544180, MAYO-MAY04-4-01, N01CN35000, NCT00474903

18.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: RV-PI-0103, 07/04, NCT00482261

19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: Under 75
Sponsor: NCI
Protocol IDs: NCI-2009-00841, CDR0000652929, NCI 04-2-03, NWU04-2-03, N01CN35157, NU-NWU04-2-03, NCT00468910

20.

Phase: Phase I
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CCUM-9215, NCI-P93-0040

21.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Unknown
Age: Not specified
Sponsor: Other
Protocol IDs: INHANSE-ASPOD, ASPOD, EU-21083, ASPOD, ISRCTN-31503555, EU-21083, NCT01238185

22.

Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7803

23.

Phase: No phase specified
Type: Prevention
Status: Closed
Age: 21 to 80
Sponsor: NCI
Protocol IDs: DMS-CPHS-10293, NCI-P95-0063

24.

Phase: No phase specified
Type: Treatment
Status: Closed
Age: 21 and over
Sponsor:
Protocol IDs: PVSG-5

25.

Phase: No phase specified
Type: Prevention
Status: Closed
Age: 75 and under
Sponsor: Other
Protocol IDs: QMC-UKCAP, EU-20045, NCT00033319
1   
New Search